BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 24889262)

  • 1. The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma.
    Kong XP; Yao J; Luo W; Feng FK; Ma JT; Ren YP; Wang DL; Bu RF
    Mol Cell Biochem; 2014 Sep; 394(1-2):177-86. PubMed ID: 24889262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma.
    Pan F; Yao J; Chen Y; Zhou C; Geng P; Mao H; Fang X
    Int J Clin Exp Pathol; 2014; 7(6):2838-49. PubMed ID: 25031703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long noncoding RNA FOXCUT promotes proliferation and migration by targeting FOXC1 in nasopharyngeal carcinoma.
    Xu YZ; Chen FF; Zhang Y; Zhao QF; Guan XL; Wang HY; Li A; Lv X; Song SS; Zhou Y; Li XJ
    Tumour Biol; 2017 Jun; 39(6):1010428317706054. PubMed ID: 28635400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.
    Li H; Jiang J
    J Investig Med; 2020 Oct; 68(7):1282-1288. PubMed ID: 32690597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forkhead box C1 promoter upstream transcript, a novel long non-coding RNA, regulates proliferation and migration in basal-like breast cancer.
    Liu J; Shen L; Yao J; Li Y; Wang Y; Chen H; Geng P
    Mol Med Rep; 2015 Apr; 11(4):3155-9. PubMed ID: 25516208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of differentially expressed lncRNAs in the pathogenesis of oral squamous cell carcinoma.
    Zhang S; Tian L; Ma P; Sun Q; Zhang K; GuanchaoWang ; Liu H; Xu B
    Arch Oral Biol; 2015 Oct; 60(10):1581-7. PubMed ID: 26276270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
    Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
    Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small nucleolar RNA host gene 3 facilitates cell proliferation and migration in oral squamous cell carcinoma via targeting nuclear transcription factor Y subunit gamma.
    Liu Z; Tao H
    J Cell Biochem; 2020 Mar; 121(3):2150-2158. PubMed ID: 31762107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
    Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
    J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.
    Arosarena OA; Dela Cadena RA; Denny MF; Bryant E; Barr EW; Thorpe R; Safadi FF
    J Cell Physiol; 2016 Aug; 231(8):1761-70. PubMed ID: 26636434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of novel prognostic markers PROX1 and FOXC2 in carcinogenesis of oral squamous cell carcinoma.
    Agnihotri NS; Astekar M
    J Exp Ther Oncol; 2018 May; 12(3):171-184. PubMed ID: 29790306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.
    Zeng J; Quan J; Xia X
    Mol Med Rep; 2016 Jan; 13(1):174-80. PubMed ID: 26549761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.
    Wu J; Li Y; Liu J; Xu Y
    J Gene Med; 2021 Mar; 23(3):e3293. PubMed ID: 33151000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
    Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
    Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
    Bu J; Bu X; Liu B; Chen F; Chen P
    Med Sci Monit; 2015 Aug; 21():2275-81. PubMed ID: 26242444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.